Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type (2022)
Attributed to:
Liquid biopsy for aggressive T-cell lymphoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000690
PubMed Identifier: 35261967
Publication URI: http://europepmc.org/abstract/MED/35261967
Type: Journal Article/Review
Parent Publication: HemaSphere
Issue: 3
ISSN: 2572-9241